Saturday, February 16, 2013

P&G Case Reflection

                During Tuesday’s class I attentively observed while the members of the consulting team presented to the panel of P&G’s C-Level executives. This was followed by period of critical questions and serious concerns posed by the executives to the consultants.  Following this decorum, I took advantage of the opportunity to voice an inquiry of my own to the consultants.  Finally, I participated in a general discussion lead by Dr. P that touched on the focal points of the case and presentation and brought closure to the event.  Coming away from this experience, I’m now in a position to reflect and critically gauge the degree of value that my case blog would have provided the C-Level Executives in aiding with their decision.

                I feel there were areas of my blog I touched on but should have given greater attention to – specifically the degree of risk involved in making a transition to web enabled EDC.  In hindsight, I would have liked to spend more time considering the alternatives than I did.  I also now wish I had evaluated the alternatives ahead of the recommended alternative as to avoid creating the appearance that they were merely an afterthought.  However, In general I feel my first case blog came pretty close to hitting the mark.  

I did not waste the C-Level’s time giving them “fluff” information about their company that they obviously knew.   I cut to the point by identifying the problem right out of the gate in my very first sentence.  I then conveyed the gravity of the problem, expressing the costs in terms I felt a CEO and CFO might truly care about — real measurable dollars.  I then immediately unveiled what I felt was the most advisable course of action to take to remediate the problem.  I outlined what I felt were all the foreseeable benefits of this recommendation and did my best to quantify these in terms of dollar yield they could contribute to P&G’s top line sales and cost savings.  I did not want to oversell this recommendation or lead the C-Level’s to believe it was a clear-cut choice free from serious costs or potential pitfalls.  I devoted a large paragraph to quantifying the associated costs of the recommendation – both those that were initial one time investments as well as variable continual costs.  I touched on some of the risks involved, specifically relating to privacy concerns, undependable internet connections and the leap of faith required in relying upon Phase Forward, a young company lacking a meaningful track record.  I feel now that I should have devoted additional attention to this area of my blog.  After the presentation, it was more apparent to me how substantial this potential move to EDC would have been for P&G a decade ago.  And the risks of adopting this new technology were far greater than I realized.  I would have spent more time voicing concerns on what a potential information systems crash could mean for a clinical trial.  Or what the results might be if investigator sites refused to adopt the technology.  I would have put greater emphasis on the fact this advised decision while carrying a great potential upside, is not an obvious decision that comes without serious risks.  

Overall, I feel I made the correct recommendation and supported it with sufficient quantifiable evidence.  While I covered the costs in great detail and touched on some of the potential risks, I feel I should have addressed other possible risks in greater scope.  Without dragging my blog out, I feel I could have explored the alternatives a bit further and would have positioned them ahead of my evaluation of the advised course of action.  I am eager to carry these takeaways forward into my next case blog.

Bobby

No comments:

Post a Comment